[Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].

We studied inhibitory activity of urinary macromolecule upon the calcium oxalate crystal aggregation using an aggregometer. We have developed an aggregometric assay method to measure the anti-aggregation ratio of calcium oxalate crystals in vitro. The macromolecular fraction of urine with a molecular weight above 5,000 was isolated by PD-10 (Sephadex G-25M, Pharmacia) and made up to three-fold by Centriprep Concentrator (Amicon). The urinary macromolecular substances of recurrent calcium stone formers showed much less inhibitory activity than those of healthy controls. There were no significant relationships between the anti-aggregation activity and the concentration of urinary proteins and other parameters concerning with stone diseases. It was speculated that some proteins, molecular weight about 10,000-30,000, might inhibit the aggregation vigorously based on the result of gel filtration (Superrose 12 HR, 20/50, Pharmacia) technique used in a healthy man's 24 hours urine. Thus, it supports that some urinary macromolecules are important during the phase of aggregation of calcium oxalate crystals, and that the feeble activity to present the aggregation may be one of the cause of calcium oxalate stone formation.

[1]  E. Neilson,et al.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Ryall,et al.  Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. , 1991, Clinical chemistry.

[3]  F. Coe,et al.  A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. , 1989, Urological research.

[4]  M. Resnick,et al.  A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. , 1988, The Journal of urology.

[5]  R. Hackett,et al.  In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. , 1988, The Journal of urology.

[6]  E. Kaiser,et al.  Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. , 1983, The Journal of biological chemistry.

[7]  M. Resnick,et al.  Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystallization. , 1982, The Journal of urology.

[8]  M. Takaha,et al.  Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. , 1981, Investigative urology.

[9]  B. Finlayson,et al.  The expectation of free and fixed particles in urinary stone disease. , 1978, Investigative urology.

[10]  B. Finlayson,et al.  Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces. , 1977, Investigative urology.

[11]  L. Smith,et al.  Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. , 1975, Investigative urology.

[12]  M. Peacock,et al.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. , 1973, Clinica chimica acta; international journal of clinical chemistry.